Evidence map›Paper›PMID 24728321›Full record

ArticlePloS one2014

COLD-PCR amplification of bisulfite-converted DNA allows the enrichment and sequencing of rare un-methylated genomic regions.

Elena Castellanos-Rizaldos, Coren A Milbury, Elli Karatza, Clark C Chen, G Mike Makrigiorgos, Anne Merewood

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Enhanced-Bio-protocol · 2019
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elena Castellanos-RizaldosDivision of DNA Repair and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.
Coren A MilburyDivision of DNA Repair and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.
Elli KaratzaDivision of DNA Repair and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.
Clark C ChenDivision of Neurosurgery, University of California San Diego, San Diego, California, United States of America.
G Mike MakrigiorgosDivision of DNA Repair and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America; Division of Medical Physics and Biophysics, Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Anne MerewoodDivision of General Pediatrics, Boston Medical Center and Boston University, Boston, Massachusetts, United States of America.

Funding

Prognostic potential of low-level mutations in meylodysplastic syndromeR21CA175542 · NCI · DANA-FARBER CANCER INST · PI MAKRIGIORGOS, G. MIKE · 2014 to 2015
$419k
Identification of Somatic Mutations in Rare Subclones of Solid TumorsR21CA155615 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HARISMENDY, OLIVIER · 2011 to 2012
$283k
Early Infant Feeding and Epigenetic Modification in Tumor Suppressor GenesR03CA139406 · NCI · BOSTON MEDICAL CENTER · PI MEREWOOD, ANNE · 2009 to 2010
$167k
NCI NIH HHS 1R03CA139406NCI NIH HHS R03 CA139406NCI NIH HHS R21 CA155615NCI NIH HHS R21CA-155615NCI NIH HHS R21 CA175542NCI NIH HHS R21CA-175542
6 · The paper itself

Abstract

Aberrant hypo-methylation of DNA is evident in a range of human diseases including cancer and diabetes. Development of sensitive assays capable of detecting traces of un-methylated DNA within methylated samples can be useful in several situations. Here we describe a new approach, fast-COLD-MS-PCR, which amplifies preferentially un-methylated DNA sequences. By employing an appropriate denaturation temperature during PCR of bi-sulfite converted DNA, fast-COLD-MS-PCR enriches un-methylated DNA and enables differential melting analysis or bisulfite sequencing. Using methylation on the MGMT gene promoter as a model, it is shown that serial dilutions of controlled methylation samples lead to the reliable sequencing of un-methylated sequences down to 0.05% un-methylated-to-methylated DNA. Screening of clinical glioma tumor and infant blood samples demonstrated that the degree of enrichment of un-methylated over methylated DNA can be modulated by the choice of denaturation temperature, providing a convenient method for analysis of partially methylated DNA or for revealing and sequencing traces of un-methylated DNA. Fast-COLD-MS-PCR can be useful for the detection of loss of methylation/imprinting in cancer, diabetes or diet-related methylation changes.

Indexed as

DNADNA MethylationPolymerase Chain ReactionSulfitesDNAhydrogen sulfiteSulfites

Identifiers

PMID24728321
PMCPMC3984089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.